Full Press Release Details
LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Valneva SE (“Valneva” or “the Company”) (NASDAQ: DAVE) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Dave investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: info@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On February 25, 2025, the U.S. Centers for Disease Control and Prevention (CDC) published a notice on its website stating that it was investigating five cases of hospitalization involving cardiac or neurological events in individuals aged 65 and older who had received IXCHIQ, Valneva’s chikungunya virus vaccine.
Following this announcement, along with subsequent media coverage, the price of Valneva’s American Depositary Receipts (ADRs) declined by $1.06, or approximately 13.57%, over the next four trading days, closing at $6.75 per ADR on February 28, 2025.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bars
Attorney Advertising